TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
39,712,986
|
36,237,639
|
31,741,662 |
| Financial expenses |
100,702
|
20,239
|
37,403 |
| Earnings before taxes |
6,192,719
|
4,884,881
|
5,693,016 |
| EBITDA |
7,857,195
|
6,446,532
|
7,246,421 |
| Total assets |
56,707,955
|
49,185,949
|
47,108,542 |
| Current assets |
43,116,012
|
36,376,949
|
33,692,804 |
| Current liabilities |
5,473,082
|
4,611,853
|
4,440,123 |
| Equity capital |
48,769,676
|
42,505,059
|
40,274,418 |
| - share capital |
1,375
|
1,332
|
1,335 |
| Employees (average) |
10,501
|
10,587
|
9,734 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
86.0%
|
86.4%
|
85.5% |
| Turnover per employee |
3,782
|
3,423
|
3,261 |
| Profit as a percentage of turnover |
15.6%
|
13.5%
|
17.9% |
| Return on assets (ROA) |
11.1%
|
10.0%
|
12.2% |
| Current ratio |
787.8%
|
788.8%
|
758.8% |
| Return on equity (ROE) |
12.7%
|
11.5%
|
14.1% |
| Change turnover |
3,475,347
|
4,495,977
|
6,013,501 |
| Change turnover % |
10%
|
14%
|
23% |
| Chg. No. of employees |
-86
|
853
|
1,398 |
| Chg. No. of employees % |
-1%
|
9%
|
17% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.